S

Stoke Therapeutics

Develops targeted gene upregulation therapies

Senior Director, Pharmacovigilance Operations & Quality

Regulatory & Quality (Life Sciences)Posted on Nov 13
Full-timeBedford, MA, USA

About the Job

Requirements

  • A bachelor's degree in life sciences, pharmacy, nursing, or a related field is required; an advanced degree (MS, PharmD, or equivalent) is preferred.
  • At least 12 years of progressively responsible pharmacovigilance experience, including a combination of PV operations and PV quality experience, and at least 5 years in a leadership role.
  • Significant experience with outsourced operating models and vendor governance.
  • Experience in PV processes for vendor oversight, individual case handling, aggregate reports, and audits or inspections.
  • Experience leading and contributing to process improvements, quality management systems, inspection readiness, Health Authority audits, and SDEA negotiations.
  • A proven track record building internal PV operations and compliance capabilities in a fast-paced, innovative environment.
  • Deep knowledge of global PV regulations, GVP, FDA regulations, and ICH guidelines.
  • Extensive working knowledge of MedDRA, WHODrug, and safety databases such as Argus and ARISg.
  • Strategic thinking, organizational and analytical skills, project management, verbal and written communication skills, and attention to detail.
  • Ability to work independently and collaboratively in a fast-paced, matrixed team environment with internal and external team members.

Responsibilities

  • Provide strategic leadership for global pharmacovigilance operations, including case management, vendor oversight, and aggregate reporting.
  • Direct development of the PV quality management system, including SOPs, work instructions, and other guidance documents, in collaboration with internal PV and Quality personnel.
  • Establish and maintain oversight and coordination of PV activities, including contracts, safety data exchange agreements, training, and reconciliation related to organized data collection systems such as market research, investigator-run trials, compassionate or expanded use, and patient support programs.
  • Own the strategic design and implementation of the company's PV training program for internal staff, field staff, and external partners, including patient support programs, specialty pharmacy distributors, and market research vendors; create role-specific content and partner with Legal, Compliance, Commercial, and Medical Affairs to embed training requirements in vendor contracts and onboarding, with KPIs to track effectiveness through commercial launch and beyond.
  • Lead PV vendor-management strategies, develop business models that optimize internal and contract resources, and ensure adequate documentation of vendor oversight.
  • Establish and oversee implementation of company standards for post-marketing surveillance, track productivity, and monitor the quality and cost of outsourced activities related to adverse-event case processing.
  • Lead development and maintenance of compliance-monitoring systems, including metrics tracking for PV activities such as submission of individual case safety reports to regulatory authorities and distribution to business partners, and aggregate report submission.
  • Establish processes, tools, and tracking mechanisms for PV department deviations, ensuring appropriate corrective and preventative actions and timely resolution of findings.
  • Hire, manage, and supervise direct reports; conduct ongoing performance reviews and staff development.
  • Ensure compliance with global PV regulations and reporting requirements.
  • Oversee operational support for DSURs, PBRERs/PSURs, PADERs, and other safety deliverables.
  • Manage PV budgets and master service agreements and statements of work with PV vendors.
  • Contribute to inspection readiness for Stoke's pharmacovigilance function.

About the Company

Stoke Therapeutics

Develops targeted gene upregulation therapies

Stoke Therapeutics develops therapies for severe genetic diseases caused by loss of function in a single gene, aiming to restore missing proteins by upregulating protein expression. Its main product approach relies on the TANGO (Targeted Augmentation of Nuclear Gene Output) platform, which delivers precise, durable, and controllable upregulation of gene expression across a range of tissues to re-create the missing protein. Compared with many biotech firms, Stoke centers on upregulating endogenous gene output rather than replacing genes or adding new ones, and focuses on disease-modifying treatments for rare disorders with unmet medical needs. Revenue comes from partnerships, licensing agreements, and, ultimately, commercialization of its therapies. The company’s goal is to provide targeted, durable treatments that address the underlying genetic deficiency and improve outcomes for patients with limited options.

Company size
201-500
Company stage
IPO
Headquarters
Bedford, TX
Founded
2014

Recently Posted Jobs

Explore more opportunities at Stoke Therapeutics

See more jobs